Bristol Myers Squibb stock holds near its yearly high

Published on 09/22/2026 at 11:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bristol Myers Squibb stock closed at USD 63.06 on September 18, 2026, up 0.35 percent from the prior close. 2026 revenue guidance is USD 49 billion to USD 50 billion.

Pharmazeutisches Forschungslabor mit NYC-Skyline, Wissenschaftler bei der Arbeit — Bristol-Myers Squibb US1078421011 zeigt Wissenschaftler in modernem New Yorker Onkologie-Labor mit Stadtpanorama, Illustration mit AI erstellt.

Bristol Myers Squibb Company (US1078421011) closed at USD 63.06 on the New York Stock Exchange on September 18, 2026, up 0.35 percent from the prior close. The price leaves Bristol Myers Squibb stock above its 52-week low of USD 42.53 and below the high of USD 68.64.

Guidance sets the valuation frame

The central operating figure is the company guidance for fiscal year 2026: revenue of USD 49 billion to USD 50 billion and non-GAAP earnings per share of USD 6.75 to USD 7.00. Ad-hoc News reported these figures on September 21, 2026, citing the updated 2026 outlook.

The latest reported quarterly comparison also points to expansion in the growth portfolio. According to Ad-hoc News on September 21, 2026, revenue reached USD 11.5 billion in the first quarter of 2026 and USD 13.0 billion in the second quarter of 2026, with year-over-year growth of about 3 percent and 6 percent, respectively.

Growth portfolio meets patent pressure

The second-quarter figure was USD 1.5 billion higher than the first-quarter figure, while the reported year-over-year growth rate doubled from 3 percent in Q1 2026 to 6 percent in Q2 2026. The comparison supports the revenue guidance, but it does not remove the longer-term pressure from patent expirations and pricing changes.

The product mix is becoming more important as established medicines face competition. Zacks reported on September 21, 2026 that its 2026 sales consensus implies 3.4 percent year-over-year growth, while its EPS consensus implies 12.36 percent growth. The same report placed the 2026 EPS estimate at USD 6.91, up from USD 6.34 over the prior 60 days.

Shares remain below the high

At USD 63.06 on September 18, 2026, the stock was USD 5.58 below the 52-week high and USD 20.53 above the 52-week low. The closing market capitalization was USD 127.0 billion, and trading volume reached 36,576,219 shares on that session.

The next earnings release is expected on October 29, 2026, with a Zacks consensus estimate of USD 1.68 per share for the quarter ending in September 2026. Zacks listed the date and estimate on September 21, 2026.

Stock stays below the yearly high

Bristol Myers Squibb stock closed at USD 63.06 on the NYSE on September 18, 2026, with the 0.35 percent daily gain, USD 127.0 billion market capitalization and 36,576,219-share volume providing the latest completed-session market context.